AGIO
Price
$43.70
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
14 days until earnings call
INSM
Price
$76.65
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
7 days until earnings call
Ad is loading...

AGIO vs INSM

Header iconAGIO vs INSM Comparison
Open Charts AGIO vs INSMBanner chart's image
Agios Pharmaceuticals
Price$43.70
Change-$0.00 (-0.00%)
Volume$495.57K
CapitalizationN/A
Insmed
Price$76.65
Change-$0.00 (-0.00%)
Volume$991.96K
CapitalizationN/A
View a ticker or compare two or three
AGIO vs INSM Comparison Chart
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INSM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AGIO vs. INSM commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a StrongBuy and INSM is a Hold.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (AGIO: $43.70 vs. INSM: $76.65)
Brand notoriety: AGIO and INSM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 106% vs. INSM: 53%
Market capitalization -- AGIO: $2.59B vs. INSM: $12.46B
AGIO [@Biotechnology] is valued at $2.59B. INSM’s [@Biotechnology] market capitalization is $12.46B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 0 FA rating(s) are green whileINSM’s FA Score has 1 green FA rating(s).

  • AGIO’s FA Score: 0 green, 5 red.
  • INSM’s FA Score: 1 green, 4 red.
According to our system of comparison, INSM is a better buy in the long-term than AGIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 6 TA indicator(s) are bullish while INSM’s TA Score has 4 bullish TA indicator(s).

  • AGIO’s TA Score: 6 bullish, 3 bearish.
  • INSM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than INSM.

Price Growth

AGIO (@Biotechnology) experienced а +6.87% price change this week, while INSM (@Biotechnology) price change was +9.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

AGIO is expected to report earnings on Feb 13, 2025.

INSM is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($12.5B) has a higher market cap than AGIO($2.6B). INSM YTD gains are higher at: 147.338 vs. AGIO (96.228). AGIO has higher annual earnings (EBITDA): -399.1M vs. INSM (-709.62M). INSM has more cash in the bank: 1.25B vs. AGIO (570M). AGIO has less debt than INSM: AGIO (64.6M) vs INSM (1.22B). INSM has higher revenues than AGIO: INSM (329M) vs AGIO (31.3M).
AGIOINSMAGIO / INSM
Capitalization2.6B12.5B21%
EBITDA-399.1M-709.62M56%
Gain YTD96.228147.33865%
P/E RatioN/AN/A-
Revenue31.3M329M10%
Total Cash570M1.25B46%
Total Debt64.6M1.22B5%
FUNDAMENTALS RATINGS
AGIO vs INSM: Fundamental Ratings
AGIO
INSM
OUTLOOK RATING
1..100
5212
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
99
Overvalued
PROFIT vs RISK RATING
1..100
7813
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
4635
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGIO's Valuation (55) in the Biotechnology industry is somewhat better than the same rating for INSM (99). This means that AGIO’s stock grew somewhat faster than INSM’s over the last 12 months.

INSM's Profit vs Risk Rating (13) in the Biotechnology industry is somewhat better than the same rating for AGIO (78). This means that INSM’s stock grew somewhat faster than AGIO’s over the last 12 months.

AGIO's SMR Rating (96) in the Biotechnology industry is in the same range as INSM (100). This means that AGIO’s stock grew similarly to INSM’s over the last 12 months.

INSM's Price Growth Rating (35) in the Biotechnology industry is in the same range as AGIO (46). This means that INSM’s stock grew similarly to AGIO’s over the last 12 months.

INSM's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AGIO (100). This means that INSM’s stock grew similarly to AGIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIOINSM
RSI
ODDS (%)
Bullish Trend 2 days ago
59%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 10 days ago
76%
Bearish Trend 25 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INSM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME21.660.39
+1.83%
GameStop Corp
BTC.X67612.720000571.609400
+0.85%
Bitcoin cryptocurrency
TSLA221.331.76
+0.80%
Tesla
SPY582.302.52
+0.43%
SPDR® S&P 500® ETF Trust
AAPL231.78-2.07
-0.89%
Apple

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with AXON. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
+3.95%
AXON - AGIO
45%
Loosely correlated
-0.07%
INSM - AGIO
44%
Loosely correlated
+2.67%
DNLI - AGIO
43%
Loosely correlated
+3.02%
ARCT - AGIO
41%
Loosely correlated
-1.62%
RAPT - AGIO
41%
Loosely correlated
-3.31%
More

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+2.67%
THAR - INSM
74%
Closely correlated
+29.67%
CALT - INSM
69%
Closely correlated
N/A
AGIO - INSM
45%
Loosely correlated
+3.95%
SRPT - INSM
44%
Loosely correlated
+1.77%
VERA - INSM
41%
Loosely correlated
-0.55%
More